Acupressure for managing anxiety and vital signs in Acute Coronary Syndrome patients
Effect of Acupressure on Anxiety, Pain and Vital Signs in Individuals Diagnosed With Acute Coronary Syndrome: A Randomized Controlled Study
This study tests whether acupressure can help reduce anxiety and improve vital signs like blood pressure and heart rate in people experiencing Acute Coronary Syndrome for the first time.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 38 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Abant Izzet Baysal University Academic / other |
| Locations | 1 site (Manisa) |
| Trial ID | NCT06300294 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of acupressure on physiological parameters and anxiety levels in individuals diagnosed with Acute Coronary Syndrome (ACS). It aims to assess how acupressure influences blood pressure, heart rate, respiratory rate, pain levels, and cortisol levels in these patients. The study includes participants who are experiencing ACS for the first time and excludes those with certain medical conditions. By combining non-pharmacological approaches with standard care, the study seeks to provide insights into alternative management strategies for ACS.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and over, diagnosed with ACS for the first time, and able to communicate in Turkish.
Not a fit: Patients with arrhythmias, previous coronary angiography, or certain other medical conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could help reduce anxiety and improve vital signs in patients with Acute Coronary Syndrome.
How similar studies have performed: Previous studies have shown positive effects of acupressure on physiological parameters and anxiety, suggesting this approach may be beneficial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Volunteer to participate in the study, * Those aged 18 and over * Able to speak Turkish * Diagnosed with ACS for the first time * Cardiopulmonary resuscitation not applied * No orientation problems (those who score 15 on the Glasgow Coma Scale) * Not diagnosed with psychiatric disease * No amputation, fistula, lymphedema, neuropathy or hemiplegia in any of the Upper Extremities * Those who underwent femoral intervention for CAG procedure * Those who have not used any integrative practices based on pressure and stimulation such as acupressure, acupuncture and reflexology in the last month. * Vital signs (28) are within normal range: Blood pressure: 90/60-120/80 mmHg Heart rate: 60-100 min Respiratory rate: 12-18 min Exclusion Criteria: * Those with arrhythmia (AF, VT etc.) * Patients who have previously undergone Coronary Angiography * Diagnosed with myocarditis, pericarditis * Those who do not take any speed-breaking drugs (beloc, arlec, etc.). * Patients who underwent radial intervention for CAG procedure
Where this trial is running
Manisa
- Manisa City Hospital — Manisa, Turkey (Türkiye) (Recruiting)
Study contacts
- Principal investigator: aynur açıkgöz, PhD student — Abant Izzet Baysal University
- Study coordinator: hospital Chief physician, Dr
- Email: manisasehir@saglik.gov.tr
- Phone: 0 236 229 26 00
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.